Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDR-END: Delamanid, Linezolid, Levofloxacin, and Pyrazinamide for MDR-TB
NCT02619994Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2016
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of delamanid in Tuberculosis (TB), sponsored by Seoul National University Hospital. Started Jan 2016; status: completed.
02
Drugs
delamanid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02619994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02619994.